PubMed

CMVR diagnoses and progression of CD4 cell counts and HIV viral load measurements in HIV patients on HAART.

Zambarakji HJ, Newson RB, Mitchell SM.

Br J Ophthalmol. 2001 Jul;85(7):837-41.PMID: 11423459 [PubMed - indexed for MEDLINE]Related articlesFree article

Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study.

Mitchell SM, Membrey WL, Youle MS, Obi A, Worrell S, Gazzard BG.

Br J Ophthalmol. 1999 Jun;83(6):652-5.PMID: 10340970 [PubMed - indexed for MEDLINE]Related articlesFree article

Influence of highly active antiretroviral therapy on the development of CMV disease in HIV positive patients at high risk for CMV disease.

Verbraak FD, Boom R, Wertheim-van Dillen PM, van den Horn GJ, Kijlstra A, de Smet MD.

Br J Ophthalmol. 1999 Oct;83(10):1186-9.PMID: 10502584 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.

Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R.

Pediatrics. 2002 Feb;109(2):E25.PMID: 11826235 [PubMed - indexed for MEDLINE]Related articlesFree article

Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: a Danish, population-based, 6-year follow-up study.

Lohse N, Kronborg G, Gerstoft J, Larsen CS, Pedersen G, Pedersen C, Sørensen HT, Obel N.

Clin Infect Dis. 2006 Jan 1;42(1):136-44. Epub 2005 Nov 30.PMID: 16323104 [PubMed - indexed for MEDLINE]Related articles

Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitis.

Walmsley SL, Raboud J, Angel JB, Mazzulli T, Shen S, Casciaro L, Young CD, Moussa G, Gough K, Rachlis A, Hopkins J.

HIV Clin Trials. 2006 Jan-Feb;7(1):1-9.PMID: 16632459 [PubMed - indexed for MEDLINE]Related articles

Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.

Kilaru KR, Kumar A, Sippy N, Carter AO, Roach TC.

HIV Med. 2006 Mar;7(2):99-104.PMID: 16420254 [PubMed - indexed for MEDLINE]Related articles

Cytomegalovirus retinitis in advanced HIV-infected patients treated with protease inhibitors: incidence and outcome over 2 years.

Labetoulle M, Goujard C, Frau E, Rogier H, Niessen F, Furlan V, Lantz O, Lecointe D, Delfraissy JF, Offret H.

J Acquir Immune Defic Syndr. 1999 Nov 1;22(3):228-34.PMID: 10770342 [PubMed - indexed for MEDLINE]Related articles

Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.

Salmon-Céron D, Mazeron MC, Chaput S, Boukli N, Senechal B, Houhou N, Katlama C, Matheron S, Fillet AM, Gozlan J, Leport C, Jeantils V, Freymuth F, Costagliola D.

AIDS. 2000 May 26;14(8):1041-9.PMID: 10853987 [PubMed - indexed for MEDLINE]Related articles

CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.

Moore RD, Keruly JC.

Clin Infect Dis. 2007 Feb 1;44(3):441-6. Epub 2006 Dec 20.PMID: 17205456 [PubMed - indexed for MEDLINE]Related articles

The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load.

Miller V, Sabin CA, Phillips AN, Rottmann C, Rabenau H, Weidmann E, Rickerts V, Findhammer S, Helm EB, Staszewski S.

AIDS. 2000 Sep 29;14(14):2129-36.PMID: 11061654 [PubMed - indexed for MEDLINE]Related articles

Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir.

Kirk O, Mocroft A, Pradier C, Bruun JN, Hemmer R, Clotet B, Miller V, Viard JP, Phillips AN, Lundgren JD; EuroSIDA Study Group.

AIDS. 2001 May 25;15(8):999-1008.PMID: 11399982 [PubMed - indexed for MEDLINE]Related articles

The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study.

Mocroft A, Phillips AN, Miller V, Gatell J, van Lunzen J, Parkin JM, Weber R, Roge B, Lazzarin A, Lundgren JD; EuroSIDA study group.

AIDS. 2001 Jan 26;15(2):201-9.PMID: 11216928 [PubMed - indexed for MEDLINE]Related articles

Effects of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV+ patients.

van den Horn GJ, Meenken C, Danner SA, Reiss P, de Smet MD.

Br J Ophthalmol. 1998 Sep;82(9):988-90.PMID: 9893585 [PubMed - indexed for MEDLINE]Related articlesFree article

Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.

Jouan M, Savès M, Tubiana R, Carcelain G, Cassoux N, Aubron-Olivier C, Fillet AM, Nciri M, Sénéchal B, Chêne G, Tural C, Lasry S, Autran B, Katlama C; RESTIMOP study team.

AIDS. 2001 Jan 5;15(1):23-31.PMID: 11192865 [PubMed - indexed for MEDLINE]Related articles

Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease.

Murphy EL, Collier AC, Kalish LA, Assmann SF, Para MF, Flanigan TP, Kumar PN, Mintz L, Wallach FR, Nemo GJ; Viral Activation Transfusion Study Investigators.

Ann Intern Med. 2001 Jul 3;135(1):17-26.PMID: 11434728 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count.

García F, de Lazzari E, Plana M, Castro P, Mestre G, Nomdedeu M, Fumero E, Martínez E, Mallolas J, Blanco JL, Miró JM, Pumarola T, Gallart T, Gatell JM.

J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):702-13.PMID: 15167289 [PubMed - indexed for MEDLINE]Related articles

CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.

McDermott AY, Terrin N, Wanke C, Skinner S, Tchetgen E, Shevitz AH.

Clin Infect Dis. 2005 Dec 1;41(11):1662-70. Epub 2005 Oct 19.PMID: 16267741 [PubMed - indexed for MEDLINE]Related articles

The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy.

Anastos K, Barrón Y, Cohen MH, Greenblatt RM, Minkoff H, Levine A, Young M, Gange SJ.

Ann Intern Med. 2004 Feb 17;140(4):256-64.PMID: 14970148 [PubMed - indexed for MEDLINE]Related articlesFree article

Antiretroviral therapy in HIV-2-infected patients: changes in plasma viral load, CD4+ cell counts, and drug resistance profiles of patients treated in Abidjan, Côte d'Ivoire.

Adjé-Touré CA, Cheingsong R, Garcìa-Lerma JG, Eholié S, Borget MY, Bouchez JM, Otten RA, Maurice C, Sassan-Morokro M, Ekpini RE, Nolan M, Chorba T, Heneine W, Nkengasong JN.

AIDS. 2003 Jul;17 Suppl 3:S49-54.PMID: 14565609 [PubMed - indexed for MEDLINE]Related articles